Evidence map›Paper›PMID 11909960›Full record

ArticleMolecular and cellular biology2002

Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.

Jennifer E Cloud, Catherine Rogers, Tammi L Reza, Ulrike Ziebold, James R Stone, Michael H Picard, Alicia M Caron, Roderick T Bronson, Jacqueline A Lees

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Critical Roles of E2F3 in Growth and Musculo-skeletal Phenotype in Mice.International journal of medical sciences · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Skin Tumors Rb(eing) Uncovered.Frontiers in oncology · 2013
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jennifer E CloudCenter for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Catherine Rogers
Tammi L Reza
Ulrike Ziebold
James R Stone
Michael H Picard
Alicia M Caron
Roderick T Bronson
Jacqueline A Lees
National Institute of Pathology · INBrigham and Women's Hospital · USHarvard University · USTufts University · US

Funding

USE OF RETROVIRUS PROMOTER TRAP VECTORS TO IDENTIFY ONCOGENES AND ANTI-ONCOGENESP01CA042063 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JACKS, TYLER E. · 1986 to 2021
$30.5M
NCI NIH HHS P01 CA042063NCI NIH HHS P01-CA42063
6 · The paper itself

Abstract

The E2F1, -2, and -3 transcription factors are key downstream targets of the retinoblastoma protein (pRB) tumor suppressor that drive expression of proliferation-associated genes. Here we use mutant mouse strains to investigate E2F3's role in vivo. We show that E2F3 is essential for embryonic viability in the pure 129/Sv background but the presence of C57BL/6 alleles yields some adult survivors. Although growth retarded, surviving E2f3(-/-) animals are initially healthy. However, they die prematurely, exhibiting no obvious tumor phenotype but with the typical signs of congestive heart failure. The defects are completely distinct from those arising in E2f1 mutant mice (S. J. Field et al., Cell 85:549-561; 1996; L. Yamasaki et al., Cell 85:537-548, 1996), supporting the prevailing view that these E2Fs must have some unique biological functions in vivo. To test this model, we examined the phenotypes of E2f1 E2f3 compound mutant mice. Almost all of the developmental and age-related defects arising in the individual E2f1 or E2f3 mice were exacerbated by the mutation of the other E2f. Thus, E2F1 and E2F3 appear to play critical, overlapping roles in the development and maintenance of a variety of tissues. Importantly, this study did identify one major difference in the properties of E2F1 and E2F3: either alone or in combination with E2F1 loss, E2f3 mutation did not increase the incidence of tumor formation. These data strongly suggest that tumor suppression is a specific property of E2F1 and not E2F3.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsAgingAnimalsAnimals, NewbornE2F1 Transcription FactorE2F3 Transcription FactorE2F Transcription FactorsEmbryonic and Fetal DevelopmentFemaleHeart FailureMaleMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsCell Cycle ProteinsDNA-Binding ProteinsE2f1 protein, mouseE2F1 Transcription FactorE2f3 protein, mouseE2F3 Transcription FactorE2F Transcription FactorsTranscription Factors

Identifiers

PMID11909960
PMCPMC133738
OpenAlexW2169129743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.